August 20, 2017 12:54 PM ET


Company Overview of Ardent Pharmaceuticals, Inc.

Company Overview

Ardent Pharmaceuticals, Inc., a biotechnology company, engages in the discovery, development, and commercialization of delta receptor compounds. It develops a range of drugs for use in moderate to severe pain, urinary incontinence, premature ejaculation, depression, cardioprotection, glaucoma, neuroprotection, immunomodulation, and drug abuse. The company’s DPI-3290 IV formulation is used for acute pain. Ardent Pharmaceuticals, Inc. was formerly known as Delta Pharmaceuticals, Inc. The company is based in Durham, North Carolina. As of 12/20/2004, Ardent Pharmaceuticals, Inc. is a subsidiary of Enhance Biotech, Inc.

631 United Drive

Suite 200

Durham, NC 27713

United States





Key Executives for Ardent Pharmaceuticals, Inc.

Chief Medical Officer and Senior Vice President for Clinical Development
Age: 66
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ardent Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at